TRIZIDIM

Ceftazidime

ANTI-INFECTIVE

INDICATION

Lower respiratory tract infections, Skin & skin structure infections, Urinary tract infections, Bacterial septicemia, Bone & joint infections, Gynecologic infections, Intra-abdominal infections, Central nervous system infections Infections associated with haemo-and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD).

DOSAGE AND ADMINISTRATION

	Dose	Frequency
Adults
Usual recommended dosage	1 g IV or IM	8-12 hourly
Uncomplicated pneumonia	500mg-1gIV or IM	8 hourly
Lung infections	30-35 mg /kg IV	8 hourly
Mild skin and skin-structure infections	500 mg – 1 g IV or IM	8 hourly
Complicated urinary tract infections	500 mg IV or IM	12 hourly
Bone & joint infections, severe life-threatening infections especially inimmunocompromised patients, Meningitis,Serious gynecologic and intra-abdominal infections	2 g IV	8 hourly
Neonates (0-4 weeks)	30 mg/kg IV	12 hourly
Infants and children(1 month – 12 years)	30-50 mg/kg IV to maximumof 6 g per day	8 hourly

Dose in dialysis : 1 g loading dose followed by 1 g after each hemodialysis period.

COMPOSITION

Trizidim® 250 mg IM / IV : Ceftazidime USP 250 mg.

Trizidim® 500 mg IM / IV : Ceftazidime USP 500 mg.

Trizidim® 1 g IM / IV : Ceftazidime USP 1 g.

Water for injection : Each ampoule contains 5 ml or 10 ml sterile water for injection BP for reconstitution